Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 733 clinical trials
Featured trial
Sternal Cerclage (sternal bone closure after open heart surgery)

The purpose of the study is to learn which treatment option is better for patients who have multi-vessel coronary artery disease (blockages in more than one vessel supplying blood to the heart muscle).

revascularisation
coronary revascularization
acute coronary syndrome
  • 1647 views
  • 05 Feb, 2021
  • 1 location
Featured trial
TAKEDA EXAMINE trial patients for who have Type II diabetes & ACS coronary artery disease, post angiogram or heart attack. This is a phase 3b study. Currently open for enrollment.

TAKEDA EXAMINE trial patients for who have Type II diabetes & ACS coronary artery disease, post angiogram or heart attack. This is a phase 3b study. Currently open for enrollment.

  • 300 views
  • 08 Nov, 2020
  • 1 location
Featured trial
ALERTS (Angel Med): Implanted device designed to continuously monitor the electrocardiogram signals and detect shifts that could indicate of a blockage of a coronary artery

ALERTS (Angel Med): Implanted device designed to continuously monitor the electrocardiogram signals and detect shifts that could indicate of a blockage of a coronary artery

  • 200 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Study for patients with stable heart failure of ischemic origin

We are carrying out a clinical trial with an investigational drug that is being developed with the intention of treating patients with heart failure of ischemic origin (heart failure characterised by a reduced blood supply to the heart). The main purpose of the study will be to assess how safe …

  • 98 views
  • 23 Nov, 2020
  • 1 location
Featured trial
ABSORB III - A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesions Absorb™ is an investigational bioabsorbable vascular scaffold manufactured by Abbott. Absorb™ is referred to as a scaffold to indicate that it is a temporary structure.

ABSORB III - A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesions Absorb™ is an investigational bioabsorbable vascular scaffold manufactured by Abbott. Absorb™ is referred to as a scaffold to indicate that it is a …

  • 120 views
  • 25 Mar, 2021
  • 1 location
Featured trial
PAD? Type II Diabetes? Diabetic Foot Ulcers?

PAD? Type II Diabetes? Diabetic Foot Ulcers?

  • 415 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Artisan

Artisan

  • 205 views
  • 08 Nov, 2020
  • 1 location
Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease

High-dose statins can reduce mortality and cardiovascular events in patients with established atherosclerotic cardiovascular disease (ASCVD). Therefore, US and European recommendations recommend that established ASCVD patients (coronary artery disease, cerebrovascular disease, peripheral vascular disease) use high-dose statins to lower LDL cholesterol levels by at least 50%. However, in actual practice, …

ezetimibe
LDL Cholesterol
rosuvastatin
hmg-coa reductase inhibitors
cardiovascular disease
  • 0 views
  • 12 Dec, 2021
  • 2 locations
MicroNet-covered Stent System for Stroke Prevention in All Comer Carotid Revascularization (PARADIGM-EXT)

All-comer study of unselected patients suitable for carotid artery revascularization to evaluate the feasibility, efficacy and safety of first line endovascular revasculariztion using MicroNet covered stent (CGuard™) in the treatment of consecutive symptomatic and increased-stroke-risk asymptomatic carotid lesions that require revascularization by Neurovascular Team decision.

angiography
stenosis
amaurosis fugax
carotid revascularization
ischemic attack
  • 1 views
  • 24 Apr, 2022
  • 1 location
Lifestyle Modification Programme for Patients With Peripheral Arterial Disease

This trial randomises patients with occlusive peripheral arterial disease, to be managed either by providing a 12-week structured lifestyle modification programme, or standard healthcare.

angiography
tobacco in any form
exposure to tobacco
peripheral vascular disease
arteriopathy
  • 29 views
  • 05 Feb, 2022
  • 1 location